Latest Breaking News On - S xrtx ca98420q2071 - Page 1 : vimarsana.com

CALGARY, Alberta, June 08, 2022 XORTX Therapeutics Inc. , a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased. | June 8, 2022

Nick rigopulosAllen davidoffExchange commissionTherapeutics incSeasons hotel westlake villageVenture exchangeGlobenewswire incAutosomal dominant polycystic kidney diseaseAnnual information formManagement discussionXortx therapeutics inc stock exchangePress releaseS xrtx ca98420q2071